Skip to main content
OpenTrials
Completed

NCT Number: NCT02926365

BIP in Jämtland Härjedalen: Increased Access to CBT Within Regular Health Care in Northern Sweden

The purpose of this study is to test internet-delivered cognitive behavior therapy for children and adolescents with anxiety disorders and obsessive-compulsive disorder in a routine clinical setting in a rural part of Sweden.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

BUP Jämtland Härjedalen

Östersund, Region Jämtland Härjedalen, Sweden

About this study

Aim The aim of this study is to conduct a pragmatic evaluation of ICBT for children and adolescents with anxiety disorders and OCD within routine health care in a rural area.

Research questions

  • Is ICBT an acceptable method for the patient group?
  • Is ICBT effective in a clinical setting?
  • Is further treatment needed after ICBT?
  • What are the long-term effects of ICBT?
  • What predicts treatment outcome?
  • How does ICBT work in a clincal setting? (time spent, negative effects etc)?

Design This is a uncontrolled intervention study where included families and children will be recruited consecutively during two years from a routine care CAMHS unit. All participants will be offered ICBT and assessed pre- and post-treatment, and at three-month follow-up through clinician ratings and self-report measures. The primary outcome measure is clinician rated severity of principal disorder at three-month follow-up. Long-term results will be assessed through study of medical records two years after completed ICBT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fulfills diagnostic criteria for an anxiety disorder or OCD
  • Access to a computer and internet connection
  • Read and speak Swedish

Exclusion criteria

  • ICBT is currently not assessed to be a suitable treatment
  • Acute psychiatric problem (eg. severe depression or suicidality)
  • Current psychosocial problems in the family (i.e substance abuse, abuse, neglect)

Treatment and study plan

ICBT

Behavioral

Primary outcomes

  1. CGI-S

    Time frame: 24 weeks from baseline

    Clinical Global Impression - Severity

Secondary outcomes

  1. CGI-S

    Time frame: 12 weeks from baseline

    Clinical Global Impression - Severity

  2. CGI-I

    Time frame: 12 and 24 weeks from baseline

    Clinical Global Impression - Improvement

  3. CGAS

    Time frame: 12 and 24 weeks from baseline

    Children's Global Assessment Scale

  4. CY-BOCS

    Time frame: 12 and 24 weeks from baseline

    Children's Yale Brown Obsessive Compulsive Scale

  5. RCADS

    Time frame: 12 and 24 weeks from baseline

    Revised Children's Anxiety and Depression Scale

  6. EWSAS

    Time frame: Week 1 through 12 + 24 weeks from baseline

    Education, Work and Social Adjustment Scale - Child and parent versions

  7. Patient satisfaction

    Time frame: 12 weeks from baseline

    Questionnaire on child- and parent rated treatment satisfaction

  8. Adverse events

    Time frame: 12 weeks from baseline

    Unintended treatment effects - child and parent version

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Official study title

Increased Access to Psychological Treatment for Children and Adolescents Through Internet-delivered CBT - a Pragmatic Evaluation Within Regular Health Care in a Rural Area of Sweden

Acronym: BIPBJÖRN

Important dates

Study start
2016
Primary completion
2019
Study completion
2022
First posted
Oct 6, 2016
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.